Revenue Recognition - Summary of Disaggregation of Revenue (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021		Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Revenue	$ 801,536	$ 670,534		$ 366,260
Product Revenue
Disaggregation of Revenue [Line Items]
Revenue	801,183	670,319	[1]	366,136	[2]
Royalty and Other Income
Disaggregation of Revenue [Line Items]
Revenue	$ 353	$ 215		$ 124

[1] 2021 revenue for filtration products includes revenue related to Polymem from July 1, 2021, as well as BioFlex and NTM from December 16, 2021 through December 31, 2021. 2021 revenue for proteins products includes revenue related to Avitide from September 20, 2021 through December 31, 2021.

[2] 2020 revenue for filtration products includes revenue related to EMT from July 13, 2020, NMS from October 20, 2020, and ARTeSYN from December 3, 2020 through December 31, 2020.